© 2003 by European Society of Cardiology
Copyright © 2003, European Society of Cardiology
Sphingosine 1-phosphate induces contraction of coronary artery smooth muscle cells via S1P2
aDepartment of Laboratory Medicine, Yamanashi Medical University, Nakakoma, Yamanashi 409-3898, Japan
bDepartment of Gastroenterology, University of Tokyo School of Medicine, Tokyo, Japan
* Corresponding author. Tel.: +81-55-273-9694; fax: +81-55-273-6924. yatomiy{at}res.yamanashi-med.ac.jp
Objectives: Sphingosine 1-phosphate (Sph-1-P), a bioactive lipid derived from activated platelets, may play an important role in coronary artery spasm and hence the pathogenesis of ischemic heart diseases, since we reported that a decrease in coronary blood flow was induced by this lysophospholipid in an in vivo canine heart model [Cardiovasc. Res. 46 (2000) 119]. In this study, metabolism related to and cellular responses elicited by Sph-1-P were examined in human coronary artery smooth muscle cells (CASMCs). Methods and results: [3H]Sphingosine (Sph), incorporated into CASMCs, was converted to [3H]Sph-1-P intracellularly, but its stimulation-dependent formation and extracellular release were not observed. Furthermore, the cell surface Sph-1-P receptors of S1P family (previously called EDG) were found to be expressed in CASMCs. Accordingly, Sph-1-P seems to act as an extracellular mediator in CASMCs. Consistent with Sph-1-P-elicited coronary vasoconstriction in vivo, Sph-1-P strongly induced CASMC contraction, which was inhibited by JTE-013, a newly-developed specific antagonist of S1P2 (EDG-5). Furthermore, C3 exoenzyme or Y-27632 inhibited the CASMC contraction induced by Sph-1-P, indicating Rho involvement. Finally, exogenously-added [3H]Sph-1-P underwent a rapid degradation. Since lipid phosphate phosphatases, ectoenzymes capable of dephosphorylating Sph-1-P, were expressed in CASMCs, Sph-1-P may be dephosphorylated by the ectophosphatases. Conclusions: Sph-1-P, derived from platelets and dephosphorylated on the cell surface, may induce the contraction of coronary artery smooth muscle cells through the S1P2/Rho signaling.
KEYWORDS Lipid metabolism; Receptor; Signal transduction; Smooth muscle; Vasoconstriction/dilation
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Hashimoto, X. Wang, L. Mao, T. Kobayashi, S. Kawasaki, N. Mori, M. L. Toews, H. J. Kim, D. R. Cerutis, X. Liu, et al. Sphingosine 1-Phosphate Potentiates Human Lung Fibroblast Chemotaxis through the S1P2 Receptor Am. J. Respir. Cell Mol. Biol., September 1, 2008; 39(3): 356 - 363. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Takabe, S. W. Paugh, S. Milstien, and S. Spiegel "Inside-Out" Signaling of Sphingosine-1-Phosphate: Therapeutic Targets Pharmacol. Rev., June 1, 2008; 60(2): 181 - 195. [Abstract] [Full Text] [PDF]
|
|